Page 41 - Key Driver News Today : Breaking News, Live Updates & Top Stories | Vimarsana

St. Martin News Network - Latest News in and around the island of St. Maarten/St. Martin.

Here's Why You Should Hold on to Nevro (NVRO) Stock Now Zacks.com 5/13/2021 Nevro Corp.  NVRO is well poised for growth on the back of its flagship platform Senza and solid international prospects. However, intense competition continues to mar prospects. Popular Searches The stock has gained 22.6% compared with the  industry’s growth of 18.2% in a year’s time. Nevro with a market capitalization of $5.25 billion is a medical device company that engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. Its trailing four...

Share this article Share this article CLEVELAND, May 11, 2021 /PRNewswire/ -- A new Freedonia Group analysis projects a strong post-pandemic rebound for the global market for off-road equipment (i.e., construction, agricultural, mining, and forestry machinery) in 2021, with demand expected to rise 5.4% to $439 billion: In 2020, the COVID-19 pandemic precipitated a sharp sales decline as demand for off-road equipment plummeted in key end-use industries – particularly construction and mining. As the pandemic recedes and revenues strengthen in these industries, however, all major off-road eq...

CBD's Role in Acute Pain Relief Tied to Patient Expectations Liz Scherer April 30, 2021 The pain-relieving effects of cannabidiol (CBD) may be linked to its influence on affective processes, new research shows. In a pilot study, investigators from the University of Syracuse, Syracuse, New York, found that patient expectectatons regarding analgesia appear to be integral to CBD's purported ability to modulate pain outcomes. "Our initial findings show that both the pharmacological action of CBD and psychological expectancies of believing that you've received CBD differentially engage and enhance...

Share this article Share this article ResearchAndMarkets.com's offering. The MDD market is a crowded and competitive market with a large number of products available for the treatment of patients; the majority of which are available as inexpensive generics. Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide, and is characterized by single or recurrent major depressive episodes (MDEs). MDD is only diagnosed if an MDE is not better explained by a psychotic disorder such as schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disor...